Finch Therapeutics Group Inc (FNCH) Return on Investment ROI from the second quarter of 2024 to second quarter of 2023 and for the year 2024, average high and low, overall ranking from Jun 30 2024 to Jun 30 2023 - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Finch Therapeutics Group Inc   (NASDAQ: FNCH)


Finch Therapeutics Group Inc's ROI from its second quarter of 2024 to the second quarter of 2023 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Finch Therapeutics Group Inc's ROI in the second quarter of 2024?
Finch Therapeutics Group Inc recorded a cumulative net loss of $-14 million during 12 months ending in the second quarter of 2024, resulting in a negative return on investment (ROI) of -69.14%.

Within the Healthcare sector 375 other companies had a higher return on investment. While Return on investment, overall ranking has progressed in the Jun 30 2024 quarter, so far to 3650, from total ROI ranking in the first quarter of 2024 at 3768.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Jun 30 2024)
II. Quarter		 (Mar 31 2024)
I. Quarter		 (Dec 31 2023)
IV. Quarter		 (Sep 30 2023)
III. Quarter		 (Jun 30 2023)
II. Quarter
Y / Y Investment Change TTM -78.7 % -83.22 % -84.64 % -69.9 % -53.95 %
Y / Y Net Income Change TTM - - - - -
Investment (TTM) in Millions 14 19 23 26 28
Return On Investment (TTM) -69.14 % -68.11 % -269.05 % -166.97 % -142.06 %
FNCH's Overall Ranking # 3650 # 3768 # 5239 # 4668 # 4767
Seq. Investment Change TTM -14.3 % -13.95 % -53.01 % -38.55 % -32.49 %
Seq. Net Income Change TTM - - - - -
Net Income (TTM) in Millions -14 -16 -75 -99 -137

FNCH Company Profile >> Back to FNCH Roi Comparisons >> See Annual FNCH Return On Investment



Return On Investment FNCH's Ranking
Within: No.
Industry # 40
Sector # 376
Overall # 3650

Return On Investment Statistics
High Average Low
-21.98 %
-58.28 %
-126.9 %
(Mar 31 2021)   (Dec 31 2023)







Financial Statements
Finch Therapeutics Group Inc's II. Quarter Investments $ 14 Millions FNCH's Balance sheet
Finch Therapeutics Group Inc's II. Quarter Income $ -5 Millions Quarterly FNCH's Income Statement
FNCH's Income by Division See FNCH's Income by Division


FNCH Annual Return On Investment (Dec 31 2023)
2023		 (Dec 31 2022)
2022		 (Dec 31 2021)
2021

Total Investments in Millions 23 148 211 0 0
Y / Y Investment Growth -84.56 % -29.6 % - - -
Net Income in Millions -75 -115 -58 0 0
Y / Y Net Income Growth - - - - -
Annual Return On Investment -326.64 % -77.33 % -27.62 % - -


Annual Roi Comment


Definition and Formula of Return on Investment

Other ROI Ratios
Biotechnology & Pharmaceuticals Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
FNCH's Roi Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for FNCH's Competitors
Subscribers only: Roi for Finch Therapeutics Group Inc's Suppliers
Subscribers only: Return On Investment for FNCH's Customers

Other Ratios
FNCH's Roa FNCH's Inventory Turnover Ratio FNCH's Growth Rates FNCH's Dividend Statistics
FNCH's Profitability Ratios FNCH's Asset Turnover Ratio FNCH's Dividend Growth
FNCH's Roe FNCH's Valuation Ratios FNCH's Financial Strength Ratios FNCH's Dividend Payout Ratio



Companies with similar Return On Investment at Jun 30 2024, within Healthcare Sector ROI

Date modified: 2026-09-26T07:39:25+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.